Evgen Pharma (EVG): Corp Phase IIb SAS data miss primary endpoint | PCI Pal (PCIP): Corp Chairman appointment
11 Nov 2019
Morning Note – 11 November 2019
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 11 November 2019
PCI-PAL PLC (PCIP:LON), 62.5 | Evgen Pharma Plc (EVG:LON), 0.8
- Published:
11 Nov 2019 -
Author:
Mark Brewer | Cavendish Research -
Pages:
4
Evgen Pharma (EVG): Corp Phase IIb SAS data miss primary endpoint | PCI Pal (PCIP): Corp Chairman appointment